US 8404635
Orally administered peptides synergize statin activity
granted A61KA61K31/22A61K31/366
Quick answer
US patent 8404635 (Orally administered peptides synergize statin activity) held by The Regents of the University of California expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/22, A61K31/366, A61K31/40, A61K31/405